Nosiheptide
CAS No. 56377-79-8
Nosiheptide( Multhiomycin | RP 9671 )
Catalog No. M24551 CAS No. 56377-79-8
Nosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 126 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 378 | In Stock |
|
| 50MG | 561 | In Stock |
|
| 100MG | 798 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNosiheptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionNosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.
-
DescriptionNosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus. Nosiheptide has been widely used as a feed additive for animal growth. Nosiheptide inhibits bacterial protein synthesis and bears a unique indole side ring system and regiospecific hydroxyl groups on the characteristic macrocyclic core.
-
In VitroNosiheptide exhibits extremely potent activity against all contemporary Staphylococcus aureus strains tested including multiple drug-resistant clinical isolates, with MIC values ≤ 0.25 mg/L. Nosiheptide is also highly active against Enterococcus spp and the contemporary hypervirulent BI strain of Clostridium difficile but is inactive against most Gram-negative strains tested. Time-kill analysis reveals Nosiheptide to be rapidly bactericidal against Staphylococcus aureus in a concentration- and time-dependent manner, with a nearly 2-log kill noted at 6 hours at 10X MIC. Furthermore, Nosiheptide is found to be non-cytotoxic against mammalian cells at >> 100X MIC, and its anti-Staphylococcus aureus activity is not inhibited by 20% human serum. Notably, Nosiheptide exhibits a significantly prolonged post-antibiotic effect against both healthcare- and community-associated Staphylococcus aureus compared to vancomycin.
-
In VivoNosiheptide (20 mg/kg; intraperitoneal injection; injected at 1 and 8 h post-infection; female CD1 mice) provids significant protection against mortality. Ten out of 10 of the Nosiheptide-treated mice remains alive on day 3, while 6/10 of the controls died on day 1. Animal Model:Eight week old female CD1 mice injected with HA-Staphylococcus aureus strain Sanger 252 Dosage:20 mg/kg Administration:Intraperitoneal injection; injected at 1 and 8 h post-infection Result:Provided significant protection against mortality.
-
SynonymsMulthiomycin | RP 9671
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic|Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56377-79-8
-
Formula Weight1222.36
-
Molecular FormulaC51H43N13O12S6
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (102.26 mM; Need ultrasonic)
-
SMILESOC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC(C4NC(C5=CSC(C(CC(C(OCC6=C7C(C)=C(NC7=CC=C6)C(SC4)=O)=O)O)NC(C8=CSC(/C(NC(C(C(O)C)NC(C9=CSC%10=N9)=O)=O)=C\C)=N8)=O)=N5)=O)=N3)C%10=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haste NM, et al. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2012 Dec;65(12):593-8.
molnova catalog
related products
-
Silver sulfadiazine
It is a topical antibiotic used in partial thickness and full thickness burns to prevent infection.
-
Cephalexin monohydra...
Cephalexin monohydrate (Cephalexin hydrate) is an orally available semi-synthetic cephalosporin antibiotic with significant antimicrobial activity that inhibits bacterial proliferation by targeting penicillin-binding proteins (PBPs).
-
(S)-5-chloro-N-(1-((...
(S)-5-chloro-N-(1-((4-chlorophenyl)amino)-1-oxo-3-phenylpropan-2-yl)-2-hydroxybenzamide has antifungal and tuberculostatic activities.
Cart
sales@molnova.com